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A Pilot Observational Study Investigating The Impact Of Glycogen Storage Disease III On Aerobic 
Capacity 
 Philip J. Hennis , David Tomlinson, Gurinder Rayat, Elaine Murphy.  
Glycogen storage disease 3 (GSDIII) is a rare inherited metabolic disorder caused by glycogen 
debranching enzyme (GDE) deficiency which primarily affects the liver, skeletal muscle and heart and 
results in muscle weakness and profound exercise limitation. Despite exercise intolerance being a 
major complication associated with the disease, the influence of GSDIII on aerobic capacity is largely 
unstudied.  
PURPOSE: To preliminary describe the impact of GSDIII on aerobic capacity and investigate potential 
mechanisms responsible for any impairment.  
METHODS: In this descriptive study 5 patients (3 female) (39 ± 11 years) with GSDIIIa underwent an 
incremental cycle exercise test to volitional exhaustion. During exercise breath-bybreath gas analysis 
took place to determine oxygen utilisation (VO2 ), carbon dioxide production (VCO2 ), and minute 
ventilation (VE) and heart rate (HR) was measured continuously. The study received institutional and 
NHS ethics approval.  
RESULTS: Peak VO2 was lower in the GSDIII patients than predicted based on their demographic data 
(16.9±8.4 ml/kg/min, 52±23% of predicted), as was peak work rate (WR) (86±59 watts, 52±30% 
predicted), peak HR (139±26 bpm, 77±11% predicted), and VE peak (30±19 L/min, 36±13%) 
predicted). Peak RER was low for a test completed to maximal exertion (0.90±0.07).  
CONCLUSION: VO2peak is lower in patients with GSDIII than would be expected for their age, height, 
mass and sex. The mechanisms responsible for this impairment are yet to be fully determined, but 
the small data set presented here indicate a reserve in respiratory and central cardiovascular 
function. Previous literature has identified energy deficiency as a primary cause of exercise 
intolerance in GSDIII due to impaired glycogen breakdown, and these results are supported here by 
the low RER values at peak exercise. 
